Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy

W.Y. Leung, Nancy; Lai, Ching‐Lung; Chang, Ting‐Tsung; Guan, Richard; Lee, Chuan–Mo; Ng, Keng–Yeen; Gee Lim, Seng; Wu, Pui‐Chee; C. Dent, Julie; Edmundson, Sally; D. Condreay, Lynn; Chien, Rong‐Nan

doi:10.1053/jhep.2001.25084

Public

Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy

Published in Hepatology • Jun 1, 2001

Authors:

Nancy W.Y. Leung

Ching‐Lung Lai

Ting‐Tsung Chang

Abstract

A study in Chinese patients with chronic hepatitis B showed that treatment with lamivudine for 1 year significantly improves liver histology and enhances hepatitis B e antigen (HBeAg) seroconversion compared with placebo. Fifty-eight patients from this 1-year study have received long-term treatment ...

Subject

Lamivudine

Medicine

Seroconversion

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!